• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GYNESONICS SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM; ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GYNESONICS SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM; ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM Back to Search Results
Model Number SONATA2-110
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Fever (1858); Unspecified Infection (1930)
Date of Event 09/23/2024
Type of Reportable Event Serious Injury
Event or Problem Description
40 yo (b)(6) at the time of treatment on (b)(6) 2024, for a 4-cm fibroid.Had bleeding with watery discharge on (b)(6) 2024 treating physician at that time and suggested it was likely due to sloughing.U/s was not remarkable other than for small fibroids, cbc wnl.The patient's sloughing sx continued and was prescribed txa earlier in (b)(6) 2025.On (b)(6) 2025, the patient presented to a different hospital where she was diagnosed with a tia (resolved on anticoagulation) and was admitted from (b)(6) through (b)(6) 2025 during which time she underwent uae.Review of the patient's mr treating physician noted a mostly/entirely non-perfused fibroid along with a largely nonperfused fibroid extruded into the cavity.There are at least two fibroids noted and in aggregate are around 8 cm.
 
Additional Manufacturer Narrative
There was no report of device malfunction during the procedure and the system functioned as expected.Submission of this report is associated with the recent acquisition of gynesonics by hologic, inc.During the integration into hologic's adverse event reporting system and procedures, a review of historical adverse events was performed.As a result, this event was identified as being reportable on (b)(6) 2025 and is being reported retroactively out of an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM
Common Device Name
ULTRASOUND-GUIDED INTRAUTERINE RADIO-FREQUENCY ABLATION SYSTEM
Manufacturer (Section D)
GYNESONICS
200 cardinal way #250
redwood city CA 94063
Manufacturer (Section G)
GYNESONICS
200 cardinal way
#250
redwood city CA
Manufacturer Contact
timothy rossi
200 cardinal way
#250
redwood, CA 94063
6502416115
MDR Report Key22964010
Report Number3005875675-2025-00061
Device Sequence Number15740929
Product Code KNF
UDI-Device Identifier10817929020326
UDI-Public(01)10817929020326
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K240503
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 09/04/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberSONATA2-110
Device Catalogue NumberSONATA2-110
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/12/2025
Initial Report FDA Received Date09/04/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Reuse
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age40 YR
Patient SexFemale
-
-